Neuren previously reported positive results in the Magel-2 mouse model of Prader-Willi syndrome, in which treatment with NNZ-2591 for 6 weeks normalized fat mass, insulin levels, IGF1 levels and all behavioural deficits.
And this is why I expect this particular trial to be keenly watched...
- Forums
- ASX - By Stock
- NEU
- Ann: Prader-Willi syndrome IND for NNZ-2591 approved by FDA
Ann: Prader-Willi syndrome IND for NNZ-2591 approved by FDA, page-5
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.86 |
Change
-0.110(0.55%) |
Mkt cap ! $2.523B |
Open | High | Low | Value | Volume |
$19.96 | $19.96 | $19.69 | $3.371M | 170.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 415 | $19.86 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.87 | 400 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 517 | 19.830 |
13 | 428 | 19.820 |
4 | 260 | 19.810 |
5 | 3478 | 19.800 |
2 | 184 | 19.790 |
Price($) | Vol. | No. |
---|---|---|
19.840 | 236 | 10 |
19.850 | 941 | 6 |
19.860 | 452 | 4 |
19.870 | 2057 | 3 |
19.880 | 1239 | 4 |
Last trade - 15.48pm 05/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |